BTRX-335140: Clinical Trials

6 trials of BTRX-335140, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 4 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1
Phase 22Completed 2

Follow BTRX-335140: new trials by email Literature Review of BTRX-335140 trials Research Report on BTRX-335140

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
NMRA-335140 80 mg, Placebo - Major Depressive Episode Associated With Bipolar II Disorder
Phase 2CompletedNeumora Therapeutics, Inc.182024-05-132026-03-30
Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
NMRA-335140, Placebo - Major Depressive Disorder
Phase 3CompletedNeumora Therapeutics, Inc.4222023-12-212026-07-06
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
NMRA-335140, Placebo - Major Depressive Disorder
Phase 3CompletedNeumora Therapeutics, Inc.4302023-12-202026-07-06
Study to Assess the Safety and Effectiveness of NMRA-335140-501
NMRA-335140 - Major Depressive Disorder
Phase 3TerminatedNeumora Therapeutics, Inc.9042023-11-102026-09-14
Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
NMRA-335140, Placebo - Major Depressive Disorder
Phase 3CompletedNeumora Therapeutics, Inc.3832023-09-202025-11-26
Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo
NMRA-335140, Placebo - Major Depressive Disorder
Phase 2CompletedNeumora Therapeutics, Inc.2042020-01-032025-05-29

Conditions studied

Depressive Disorder, Major (5)  ·  Bipolar Disorder (1)

Sponsors

Neumora Therapeutics, Inc. (6)

Countries

United States (6)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  Chile (2)  ·  Czechia (2)  ·  Finland (2)  ·  France (2)  ·  Germany (2)  ·  Poland (2)  ·  Sweden (2)

Results publications

PMID 40199329